Accelerate Diagnostics

Accelerate Diagnostics is dedicated to providing cutting-edge solutions in the field of in vitro diagnostics, specifically addressing the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics is at the forefront of medical technology, striving to improve patient outcomes through rapid and accurate diagnostic tools. Located at 3950 South Country Club Road, Tucson, AZ 85714, US, Accelerate Diagnostics is committed to innovation and excellence in the medical device industry.

The company's flagship product, the Accelerate Pheno® system, along with the Accelerate PhenoTest® BC kit, integrates advanced technologies to significantly reduce the time required for clinicians to determine the most effective antibiotic therapy for severe infections. This system automates sample preparation, delivering phenotypic antibiotic susceptibility results in approximately 7 hours directly from positive blood cultures. Accelerate Diagnostics is focused on enhancing the speed and accuracy of diagnostic processes.

External studies have demonstrated that Accelerate Diagnostics' solutions offer results 1–2 days faster than traditional methods, empowering clinicians to optimize antibiotic selection and dosage tailored to individual patients much earlier. This advancement allows for more precise and timely treatment, ultimately improving patient care and reducing the spread of antibiotic-resistant infections. Accelerate Diagnostics continues to push the boundaries of diagnostic capabilities in the medical field. We invite the management team at Accelerate Diagnostics to create a customized and exclusive company showcase and product listing on our platform to further highlight these advancements.